KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 120 filers reported holding KALVISTA PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 1.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2 | 0.0% | 154 | 0.0% | 0.00% | – |
| Q1 2024 | $2 | -99.8% | 154 | +234.8% | 0.00% | – |
| Q3 2022 | $1,000 | – | 46 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 46 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 46 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 46 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 46 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 46 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 46 | +35.3% | 0.00% | – |
| Q4 2020 | $1,000 | – | 34 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,719,576 | $13,155,000 | 11.03% |
| INTERWEST VENTURE MANAGEMENT CO | 388,766 | $2,974,000 | 3.14% |
| Vivo Capital, LLC | 1,476,796 | $11,297,000 | 1.02% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 227,433 | $1,731,000 | 0.79% |
| DAFNA Capital Management LLC | 234,952 | $1,797,000 | 0.75% |
| Samsara BioCapital, LLC | 168,174 | $1,287,000 | 0.74% |
| Ghost Tree Capital, LLC | 350,000 | $2,678,000 | 0.71% |
| Ikarian Capital, LLC | 946,605 | $7,242,000 | 0.54% |
| Opaleye Management Inc. | 225,000 | $1,721,000 | 0.46% |
| Eventide Asset Management | 1,680,000 | $12,852,000 | 0.42% |